Registered Nurse in York, NE Accepting Medicare

7 Registered Nurse nurses found. Showing 1 - 7

Ms. Donelle Ellison, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2119 N Division Ave, York, NE 68467 Phone: 402-362-3353

Atley Jnel Henderson, RN Registered Nurse - School Medicare: Not Enrolled in Medicare Practice Location: 1501 Washington Ave, York, NE 68467 Phone: 402-362-1414

Mrs. Patricia Arena Bailey, APRN-FNP Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 805 Road Q, York, NE 68467 Phone: 402-710-2114

Mrs. Laura Lee Miller, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2119 Division Ave., York, NE 68467 Phone: 402-362-3353    Fax: 402-362-3248

Mrs. Holly Gae Eckhart, RN Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 223 E 8th St, York, NE 68467 Phone: 402-710-0564

Mrs. Lora Jean Winter, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2119 Division Ave, York, NE 68467 Phone: 402-362-3353    Fax: 402-362-3248

Becky Lanae Shafer, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1730 N Delaware Ave, York, NE 68467 Phone: 402-362-6655

News Archive

Applied Spine Technologies announces first patient surgery to test safety and effectiveness of Stabilimax system

Applied Spine Technologies (www.appliedspine.com) announces the first patient surgery at Allegheny General Hospital in Pittsburgh, Pennsylvania, as part of their FDA approved Investigational Device Exemption (IDE) clinical trial designed to evaluate the safety and effectiveness of the Stabilimax® Dynamic Spine Stabilization System.

NIH study helps explain survival rate discrepancy between cardiac arrest in public and home

Cardiac arrests that can be treated by electric stimulation, also known as shockable arrests, were found at a higher frequency in public settings than in the home, according to a National Institutes of Health-funded study appearing in the Jan. 27 issue of the New England Journal of Medicine.

Maxygen initiates Phase I study to evaluate CTLA4-Ig therapeutic for treatment of rheumatoid arthritis

Maxygen, a biotechnology company focused on the development of improved protein drugs, today announced the initiation of a Phase I clinical study to evaluate a next-generation CTLA4-Ig therapeutic that is being developed by Perseid Therapeutics LLC, Maxygen's majority-owned subsidiary, in collaboration with Astellas Pharma Inc. for the treatment of rheumatoid arthritis and potentially other autoimmune indications.

Ocimum Biosolutions ranked 42nd on the Deloitte Technology Fast 500 Asia Pacific 2009

Ocimum Biosolutions, a leading integrated genomics company, today announced that it ranked 42nd on the Deloitte Technology Fast 500 Asia Pacific 2009, a ranking of the 500 fastest growing technology companies in Asia Pacific. Rankings are based on percentage revenue growth over three years. In addition to ranking on Deloitte's Technology Fast 500, Ocimum ranked fourth on the Technology Fast 50 India Program, which is a ranking of the 50 fastest growing technology firms in India.

Read more Medical News

› Verified 3 days ago